|
|
AT A GLANCEGlossary |
|
|
Introduction |
|
|
Welcome to the UCSF AGRC course in Geriatrics and Gerontology |
|
|
Course Topics |
|
|
Overall Course Goals |
|
|
Philosophy |
|
|
Faculty |
|
|
Why Take This Course? |
|
|
The Multifaceted Face of Aging: 3 Cases |
|
|
Discussion of the Three Preceding Cases |
|
|
How To Use This Course |
|
|
Where To Start? |
|
|
Then What? |
|
|
How to Start--Case 1 |
|
|
How to Start--Case 2 |
|
|
Reflection on Two Cases |
|
|
Post Test |
|
|
Demography And Epidemiology |
|
|
The Changing Face of Aging: Objectives |
|
|
Local and Regional Variations Among Older Adults in the United States |
|
|
Implications of an Aging Society for Health Care Needs and Resources |
|
|
Common Chronic Conditions Associated with Advanced Age |
|
|
Post Test |
|
|
Biology and Physiology of Aging |
|
|
Introduction and Background |
| 2.1.1 | Table of Contents |
| 2.1.2 | Module Learning Objectives |
| 2.1.3 | Personal Exercise |
| 2.1.4 | Case Background |
| 2.1.5 | Historical View of Aging |
| 2.1.6 | Successful Aging |
| 2.1.7 | What is the Truth about Aging? |
| 2.1.8 | When Pathologies are Attributed to Aging |
| 2.1.9 | Aging or Disease? |
| 2.1.10 | Understanding Age-Related Changes |
|
|
Theories of Aging |
|
|
Physiological Changes with Aging |
|
|
Pharmacologic Considerations |
|
|
Post Test |
|
|
Socio-cultural And Psychologicial… |
|
|
Module Objectives |
|
|
Social Theories of Aging |
| 3.2.1 | Modernization Theory |
| 3.2.2 | Modernization Theory (II) |
| 3.2.3 | Criticisms of Modernization Theory |
| 3.2.4 | Role Theory |
| 3.2.5 | Role Theory (II) |
| 3.2.6 | Criticisms of Role Theory |
| 3.2.7 | Disengagement Theory |
| 3.2.8 | Activity Theory |
| 3.2.9 | Reflections (III) |
|
|
Psychological Development In Late Life |
|
|
Ethno-Cultural Issues And Age-Stratified Societies |
|
|
Late-Life Transitions |
| 3.5.1 | Normative Transitions in Later Life |
| 3.5.2 | "Off Time" Transitions |
| 3.5.3 | Reflections (VII) |
|
|
Dependent Elders: Special Concerns |
| 3.6.1 | Adult Guardianship in Euro-American Societies |
| 3.6.2 | Elder Abuse |
| 3.6.3 | Caregiving: Informal |
| 3.6.4 | Caregiving: Formal |
| 3.6.5 | Residential Care |
| 3.6.6 | Ageism and Therapeutic Nihilism |
|
|
Cultural Views of Death |
| 3.7.1 | Funeral Rites |
| 3.7.2 | The "Good Death" |
| 3.7.3 | End of Life Care |
|
|
References |
|
|
Post Test |
|
|
Assessment Of The Geriatric… |
|
|
Module Objectives |
|
|
Domains of Assessment: Functional Assessment |
|
|
Domains Of Assessment: Psychosocial Health And Functioning |
| 4.3.1 | Informal Caregiving Support Network |
| 4.3.2 | Abuse and Neglect |
| 4.3.3 | Social Support |
| 4.3.4 | Spiritual and Cultural Assessment |
| 4.3.5 | Home Assessment |
|
|
Special Considerations In Assessment |
|
|
Post Test |
|
|
Health Care Policies |
|
|
Module Objectives |
|
|
The Policy-Making Process |
|
|
Financing Health & Long Term Care |
|
|
Quality Of Care Issues In Long Term Care |
|
|
Need And Access Across The Spectrum Of Care |
|
|
References |
|
|
Post Test |
|
|
Exploring Age-Related Body… |
|
|
Cardiovascular System |
| 6.1.1 | Case 1 |
| 6.1.2 | Case 2 |
| 6.1.3 | The Cardiovascular System |
| 6.1.4 | Can These Changes Be Modified? |
| 6.1.5 | Sodium and Activity |
| 6.1.6 | Atherosclerosis |
| 6.1.7 | What Can We Do About The Process? |
| 6.1.8 | Links to Theories of Aging |
| 6.1.9 | Myocardium |
| 6.1.10 | Clinical Implications |
| 6.1.11 | Cellular Calcium |
| 6.1.12 | Functional Changes |
| 6.1.13 | Pulse Wave Velocity |
| 6.1.14 | Additional Functional Changes |
| 6.1.15 | Clinical Significance |
| 6.1.16 | Response to Stress |
| 6.1.17 | Congestive Heart Failure |
| 6.1.18 | Diastolic Versus Systolic Heart Failure |
| 6.1.19 | Case 3 |
| 6.1.20 | Case 3: Points To Consider |
| 6.1.21 | References |
| 6.1.22 | Review Question 1 |
| 6.1.23 | Review Question 2 |
|
|
Endocrine System |
| 6.2.1 | Case 1: Mr. Jones |
| 6.2.2 | Circadian Rhythms |
| 6.2.3 | Hypothalamic-Pituitary and Hypothalamic-Pituitary-Adrenal Axis |
| 6.2.4 | Growth Hormone |
| 6.2.5 | Why Does Growth Hormone Decrease? |
| 6.2.6 | Why is Growth Hormone Important to Our Clinical Practice? |
| 6.2.7 | Is This Good Clinical Practice? |
| 6.2.8 | Case 2: Discussion |
| 6.2.9 | CRH, Adrenocorticotropic Hormone/Corticotropin (ACTH), and Cortisol |
| 6.2.10 | Aging, the Stress Response, Cortisol, and Cognitive Function |
| 6.2.11 | Aldosterone |
| 6.2.12 | Dehydroepiandrosterone (DHEA) |
| 6.2.13 | The Adrenal Medulla |
| 6.2.14 | Hypothalamic-Pituitary-Thyroid Axis |
| 6.2.15 | Posterior Pituitary |
| 6.2.16 | Case 3: Clinical |
| 6.2.17 | Endocrine Pancreas |
| 6.2.18 | What Causes These Changes? |
| 6.2.19 | Can These Changes Be Prevented? |
| 6.2.20 | What Do We See Clinically? |
| 6.2.21 | Discussion Point |
| 6.2.22 | Should Age-Related Changes in Carbohydrate Metabolism Be Treated? |
| 6.2.23 | Summary Case and Evaluation Questions |
| 6.2.24 | References |
| 6.2.25 | Review Question 1 |
| 6.2.26 | Review Question 2 |
|
|
Immune System |
| 6.3.1 | Setting the Stage |
| 6.3.2 | Setting the Stage 2 |
| 6.3.3 | Overview and Background |
| 6.3.4 | What Happens with Age? |
| 6.3.5 | Non-Specific Immunity |
| 6.3.6 | The Physical Barriers |
| 6.3.7 | Acid Contents of the Stomach |
| 6.3.8 | Phagocytosis |
| 6.3.9 | The Macrophage |
| 6.3.10 | The "Natural Killer" and the "LAK" |
| 6.3.11 | Non-Specific Summary |
| 6.3.12 | Specific Immunity |
| 6.3.13 | What Happens to Specific Immunity With Age? |
| 6.3.14 | The Immune Response |
| 6.3.15 | References |
|
|
Musculo-Skeletal System |
| 6.4.1 | Case 1 |
| 6.4.2 | Case 1 Continued |
| 6.4.3 | The Inter-Relationship of the Muscle and Skeletal System |
| 6.4.4 | Muscle Changes and Function with Age |
| 6.4.5 | Changes in Muscle with Age |
| 6.4.6 | Muscle Fibers |
| 6.4.7 | What Are The Physiologic Processes That Cause These Changes? |
| 6.4.8 | What Is The Impact Of These Changes On Function? |
| 6.4.9 | Mobility Changes |
| 6.4.10 | Interventions to Minimize Changes |
| 6.4.11 | Discussion Point |
| 6.4.12 | Joints, Tendons, and Ligaments |
| 6.4.13 | Differences in Cartilage Between Aging and Osteoarthritis |
| 6.4.14 | Skeletal Changes With Age |
| 6.4.15 | Bone Components |
| 6.4.16 | Many Factors Influence Bone Health |
| 6.4.17 | Bone Loss |
| 6.4.18 | General Changes in the Bone with Age |
| 6.4.19 | Factors Influencing Whether a Fracture Will Or Will Not Occur |
| 6.4.20 | Summary Case |
| 6.4.21 | References |
|
|
Neurological System |
|
|
Renal System |
|
|
Post Test |
Module 6: Exploring Age-Related Body Systems Changes6.5: Neurological System6.5.5: Changes with AgeA number of changes have already been alluded to in relation to the neuron, several of which we will discuss in more detail further on in the module. First, however, it’s helpful to get an overall idea of the changes that occur in the brain with age that need to be considered when caring for an older adult. The brain gets smaller as we age (atrophy) and experiences a decrease in weight, changes that are generally attributed to loss of neurons. Note that it is important to differentiate between neurons and neuroglia (definitions). Neurons are differentiated and generally non-replaceable, although some recent data have called this latter belief into question. In contrast, neuroglia can undergo cell division and proliferate, a point we’ll come back to. While loss of neurons occurs, it is localized to specific layers and regions of the brain and shows considerable individual variability (Timeras, 1994). Thus data are often conflicting, a problem that is exacerbated by the difficulties inherent in studying changes in humans rather than animals. Losses in the locus ceruleus, a major source of catacholaminergic neurons, and the substantia nigra, which is part of the basal ganglia and a major source of dopaminergic neurons, have been reported and may be a factor in age changes in stability, gait, homeostasis, and sleep as well as cognitive functioning (Reeves, et al., 2002; Timeras, 1994). On the other hand, loses in the nucleus basalis of Meynert (an area of the Amygdala), which is a major source of cholinergic neurons, occur mainly in persons with Alzheimer’s type dementia, with relatively minor changes occurring in non-demented elders (Timeras, 1994). In general, changes tend to affect the white matter (myelinated neurons) to a greater extent than the gray matter (Mrak, et al., 1997). This may be consistent with the the idea that retrogenesis occurs with age and may underpin a number of neurodegenerative conditions (Braak, et al., 1999; Reisberg, et al., 1999). Retrogenesis is defined as “the process by which degenerative mechanisms reverse the order of acquisition in normal development” (Reisberg, et al., 1999). According to this hypothesis, the parts of the brain that undergo late myelination are first to undergo demyelination and the development of pathologic intra- and extra- cellular changes. While more data are needed to support this process, it has been linked to the stages of development of Alzheimer’s disease and related clinical findings (Braak, et al., 1999; Reisberg, et al., 1999). |
